TMDX

TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System

TransMedics Group's stock is halted in advance of FDA committee meeting

TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System

TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting

TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021)

David Abrams Buys 3 Stocks in 1st Quarter

Transmedics Group, Inc. (TMDX) CEO Waleed Hassanein on Q1 2021 Results - Earnings Call Transcript